26 results
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
and Secretary, in consideration for an annualized salary of $410,000. The Employment Agreement provides for a signing bonus of $56,666.00. The Employment … Agreement contemplates an annual cash bonus, as determined by the Board in its sole discretion and in good faith. The target cash bonus is 50% of Mr
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
and Secretary, in consideration for an annualized salary of $410,000. The Employment Agreement provides for a signing bonus of $56,666.00. The Employment … Agreement contemplates an annual cash bonus, as determined by the Board in its sole discretion and in good faith. The target cash bonus is 50% of Mr
10-Q
2024 Q1
EX-10.3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
.
Signing Bonus. Executive shall be paid a signing bonus of $56,666.00 (the “Signing Bonus”), less applicable taxes and withholdings, representing … for the period from January 1, 2024 through April 30, 2024. The Signing Bonus shall be paid within ten (10) days of the Effective Date and only
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
Agreement provides for a signing bonus of $56,666.00. The Employment Agreement contemplates an annual cash bonus, as determined by the Board in its … sole discretion and in good faith. The target cash bonus is 50% of Mr. Knuettel’s annualized salary and will be based on achievement of performance
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
-based compensation awards and cash-based performance bonus awards.
In addition, we have a three person Scientific Advisory Board led by Dr. Stephen … Bonus Shares (as defined below), received by holders of the senior secured convertible notes upon conversion of such notes.
In connection with our
424B3
w3m3v
16 Apr 24
Prospectus supplement
5:45pm
10-K
yqp xa131wdjtz8
16 Apr 24
Annual report
4:48pm
10-K
EX-97.1
oaws84v6h ulk1
16 Apr 24
Annual report
4:48pm
8-K
EX-1.1
gnnp2 kqz
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
hsgq9
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
78w9q87
20 Feb 24
Prospectus supplement with pricing info
5:28pm